Trisenox and pleural effusion 
Trisenox and pleural effusion Patient Reports February 13, 2012
Trisenox Side Effects Report #5027342-3
Trisenox side effect was reported by a Physician from UNITED STATES on May 30, 2006. Female patient, 70 years of age, was diagnosed with myeloproliferative disorder and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cardiac tamponade, pericardial effusion, pleural effusion, pneumonia
. Trisenox dosage: 18 MG Q72HR INTRAVENOUS DRIP. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ASCORBIC ACID. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5041520-9
Trisenox side effect was reported by a Physician from UNITED STATES on June 14, 2006. Female patient, 70 years of age, was diagnosed with myeloproliferative disorder and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cardiac tamponade, pericardial effusion, pleural effusion, pneumonia primary atypical, shoulder pain. Trisenox dosage: 18 MG Q72HR INTRAVENOUS DRIP. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ASCORBIC ACID. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5233337-7
Trisenox side effect was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 76 years of age, weighting 187.0 lb, was diagnosed with myelodysplastic syndrome, iron overload and was treated with Trisenox. After drug was administered, patient experienced the following side effects: ascites, cardiac failure congestive, electrocardiogram qt prolonged, fluid overload, mitral valve incompetence, pleural effusion, pneumonia
, splenomegaly, tricuspid valve incompetence. Trisenox dosage: 0.25 MG/KG TWICE WEEKLY Q72HR INTRAVENOUS DRIP. During the same period patient was treated with EXJADE, THALIDOMIDE, ACYCLOVIR, ASCORBIC ACID. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5853402-0
Trisenox side effect was reported by a Physician from ITALY on Feb 12, 2008. Female patient, 72 years of age, weighting 143.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, gastrointestinal toxicity, pleural effusion, pneumonia
. Trisenox dosage: unknown. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5853387-7
Trisenox side effect was reported by a Physician from ITALY on Sept 04, 2007. Female patient, 67 years of age, weighting 145.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, atrial fibrillation
, electrocardiogram qt prolonged, pleural effusion, pneumonia , weight increased. Trisenox dosage: unknown. During the same period patient was treated with AXAGON, SYLORIC, RAMIPRIL, GLIBOMET, INSULINE NPH. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #4664229-X
Trisenox side effect was reported by a Physician from on May 04, 2005. Male patient, 75 years of age, weighting 156.1 lb, was diagnosed with multiple myeloma
and was treated with Trisenox. After drug was administered, patient experienced the following side effects: ascites, blood creatinine increased, blood urea increased, intestinal obstruction, nausea , pericardial effusion, pleural effusion. Trisenox dosage: 18 MG (18 MG, BIW), IVI. During the same period patient was treated with ASCORBIC ACID, THALOMID. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5491898-7
Trisenox side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2007. Male patient, 70 years of age, weighting 200.6 lb, was diagnosed with multiple myeloma
and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute respiratory failure, atelectasis, febrile neutropenia, pleural effusion. Trisenox dosage: 0.25 MG/KG INTRAVENOUS. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5768221-3
Trisenox side effect was reported by a Physician from JAPAN on May 26, 2008. Male patient, 85 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, diarrhoea, electrocardiogram qt prolonged, hepatic function abnormal, hyperglycaemia, leukocytosis, pleural effusion, pneumonia
. Trisenox dosage: 8.4 MG DAILY INTRAVENOUS. During the same period patient was treated with GABAXATE MESILATE. Patient recovered.Trisenox Side Effects Report #5361222-9
Trisenox side effect was reported by a Physician from JAPAN on June 04, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood pressure systolic decreased, bone marrow failure, c-reactive protein increased, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pleural effusion, respiratory arrest, urine output decreased. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, PREDNISOLONE SUCCINATE, NAFAMOSTAT, LENOGRASTIM. Patient died on 05/06/2007.
Trisenox Side Effects Report #5391724-0
Trisenox side effect was reported by a Physician from JAPAN on July 10, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood pressure systolic decreased, bone marrow failure, c-reactive protein increased, pleural effusion, rash
, respiratory arrest, resuscitation, urine output decreased. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, PREDNISOLONE SUCCINATE, NEFAMOSTAT, LENOGRASTIM. Patient died on 05/06/2007.Trisenox Side Effects Report #5912530-1
Trisenox side effect was reported by a Physician from JAPAN on Aug 05, 2008. Male patient, 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, pericardial effusion, pleural effusion, ventricular tachycardia. Trisenox dosage: 12.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, LANATOSIDE C, HYDROCORTISONE SUCCINATE, FUROSEMIDE, ELECTROLYTE. Patient recovered.
Trisenox Side Effects Report #5959554-6
Trisenox side effect was reported by a Physician from JAPAN on Nov 06, 2008. Male patient, 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, pericardial effusion, pleural effusion, ventricular tachycardia. Trisenox dosage: 12.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, LANATOSIDE C, HYDROCORTISONE SUCCINATE, FUROSEMIDE, ELECTROLYTE, ELECTORLYTE. Patient recovered.
Trisenox Side Effects Report #5976516-3
Trisenox side effect was reported by a Physician from JAPAN on Nov 12, 2008. Male patient, 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, pericardial effusion, pleural effusion, ventricular tachycardia. Trisenox dosage: 12.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LANATOSIDE C, HYDROCORTISONE SUCCINATE, FUROSEMIDE, ELECTROLYTE. Patient recovered.
Trisenox Side Effects Report #4678283-2
Trisenox side effect was reported by a Physician from on Dec 27, 2004. Male patient, 55 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, body temperature increased, c-reactive protein increased, constipation
, dyspnoea, hypoxia, pleural effusion. Trisenox dosage: 12.3 MG (12.3 MG, DAILY), INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #4697856-4
Trisenox side effect was reported by a Physician from on June 02, 2005. Male patient, 55 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, body temperature increased, constipation
, pleural effusion. Trisenox dosage: 12.3 MG (12.3 MG DAILY) INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #4603180-8
Trisenox side effect was reported by a Physician from on Feb 16, 2005. Female patient, 54 years of age, was diagnosed with acute promyelocytic leukaemia, infection prophylaxis and was treated with Trisenox. After drug was administered, patient experienced the following side effects: chest pain
, disseminated intravascular coagulation, interstitial lung disease, pleural effusion, retinoic acid syndrome, white blood cell count increased. Trisenox dosage: unknown. During the same period patient was treated with NEUPOGEN, AMPHOTERICIN B, POLYMYXIN B SULPHATE. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5320868-4
Trisenox side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, ascites, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, neuropathy peripheral, pancytopenia, pleural effusion, respiratory failure, weight increased. Trisenox dosage: 8.25 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, FUROSEMIDE, DANAPAROID. Patient recovered.
Trisenox Side Effects Report #4568375-0
Trisenox side effect was reported by a Physician from on Jan 13, 2005. Female patient, 51 years of age, was diagnosed with acute promyelocytic leukaemia, infection prophylaxis and was treated with Trisenox. After drug was administered, patient experienced the following side effects: chest pain
, interstitial lung disease, pleural effusion, white blood cell count increased. Trisenox dosage: unknown. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #6084441-5
Trisenox side effect was reported by a Physician from JAPAN on Feb 05, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, electrocardiogram qt prolonged, febrile neutropenia, leukocytosis, pleural effusion, renal impairment, respiratory disorder, sepsis
, septic shock. Trisenox dosage: 11 MG QD INTRAVENOUS DRIP. Patient died on 01/30/2009.Trisenox Side Effects Report #6106670-4
Trisenox side effect was reported by a Physician from JAPAN on Feb 17, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, electrocardiogram qt prolonged, febrile neutropenia, leukocytosis, neutrophil count decreased, pleural effusion, renal impairment, respiratory disorder, septic shock. Trisenox dosage: 11 MG QD, INTRAVENOUS DRIP. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, IDARUBICIN HYDROCHLORIDE, ITRACONAZOLE, POTASSIUM CHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SENNOSIDE. Patient died on 01/30/2009.
Trisenox Side Effects Report #6108252-7
Trisenox side effect was reported by a Physician from JAPAN on Feb 17, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, pleural effusion, respiratory disorder, septic shock, weight increased. Trisenox dosage: 11 MG QD INTRAVENOUS DRIP. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, IDARUBICIN HYDROCHLORIDE, ITRACONAZOLE, POTASSIUM CHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LOXOPROFEN. Patient died on 01/30/2009.
Trisenox Side Effects Report #6088489-6
Trisenox side effect was reported by a Health Professional from JAPAN on Feb 09, 2009. Male patient, 25 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: chest pain
, haemodynamic instability, pericardial effusion, pleural effusion. Trisenox dosage: 10 MG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #6108673-2
Trisenox side effect was reported by a Health Professional from JAPAN on Feb 23, 2009. Male patient, 25 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cardiac tamponade, chest pain
, haemoglobin decreased, hepatic enzyme increased, melaena, pericardial effusion, pleural effusion. Trisenox dosage: 10 MG QD INTRAVENOUS DRIP. During the same period patient was treated with PHENYTOIN, TOSUFLOXACIN TOSILATE, OXETHAZAINE, LANSOPRAZOLE, VALPROATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ALENDRONATE, BROTIZOLAM. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #6141226-9
Trisenox side effect was reported by a Health Professional from JAPAN on Mar 19, 2009. Male patient, 25 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cardiac tamponade, cardiovascular insufficiency, gastrointestinal haemorrhage, haemoglobin decreased, hepatic enzyme increased, pericardial effusion, pleural effusion. Trisenox dosage: 10 MG (10 MG, 1 IN 1 D), INTRAVENOUS DRIP. During the same period patient was treated with PHENYTOIN, TOSULFOXACIN TOSILATE, OXETHAZAINE, LANSOPRAZOLE, VALPROATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ALENDRONATE HYDRATE, BROTIZOLAM. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #4553545-8
Trisenox side effect was reported by a Health Professional from on Dec 27, 2004. Male patient was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: c-reactive protein increased, dyspnoea, pleural effusion. Trisenox dosage: 12 MG (12 MG, DAILY), INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.